Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Jody Corey-Bloom

    TitleEmeritus Professor
    SchoolUniversity of California, San Diego
    DepartmentNeurosciences
    Address9500 Gilman Drive #0948
    CA La Jolla 92093
    Phone858-246-1288
    vCardDownload vCard

      Collapse Research 
      Collapse Research Activities and Funding
      UCSD Alzheimer's Disease Research Center P50
      NIH/NIA P50AG005131Sep 28, 1984 - Mar 31, 2019
      Role: Co-Investigator
      General Clinical Research Center
      NIH/NCRR M01RR000827Mar 1, 1974 - Nov 30, 2010
      Role: Co-Investigator

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Graves LV, Van Etten EJ, Holden HM, Delano-Wood L, Bondi MW, Corey-Bloom J, Delis DC, Gilbert PE. Refining CVLT-II recognition discriminability indices to enhance the characterization of recognition memory changes in healthy aging. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2017 Aug 31; 1-16. PMID: 28857679.
        View in: PubMed
      2. Doyle KL, Woods SP, McDonald CR, Leyden KM, Holden HM, E Morgan E, Gilbert PE, Corey-Bloom J. Verbal episodic memory profiles in HIV-Associated Neurocognitive Disorders (HAND): A comparison with Huntington's disease and mesial temporal lobe epilepsy. Appl Neuropsychol Adult. 2017 Aug 29; 1-11. PMID: 28850256.
        View in: PubMed
      3. Corey-Bloom J, Aikin AM, Gutierrez AM, Nadhem JS, Howell TL, Thomas EA. Beneficial effects of glatiramer acetate in Huntington's disease mouse models: Evidence for BDNF-elevating and immunomodulatory mechanisms. Brain Res. 2017 Oct 15; 1673:102-110. PMID: 28823953.
        View in: PubMed
      4. Sheth VR, Fan S, He Q, Ma Y, Annese J, Switzer R, Corey-Bloom J, Bydder GM, Du J. Inversion recovery ultrashort echo time magnetic resonance imaging: A method for simultaneous direct detection of myelin and high signal demonstration of iron deposition in the brain - A feasibility study. Magn Reson Imaging. 2017 May; 38:87-94. PMID: 28038965.
        View in: PubMed
      5. Van Liew C, Santoro MS, Goldstein J, Gluhm S, Gilbert PE, Corey-Bloom J. Evaluating Recall and Recognition Memory Using the Montreal Cognitive Assessment: Applicability for Alzheimer's and Huntington's Diseases. Am J Alzheimers Dis Other Demen. 2016 Dec; 31(8):658-663. PMID: 27678491.
        View in: PubMed
      6. Harmell AL, Neikrug AB, Palmer BW, Avanzino JA, Liu L, Maglione JE, Natarajan L, Corey-Bloom J, Loredo JS, Ancoli-Israel S. Obstructive Sleep Apnea and Cognition in Parkinson's disease. Sleep Med. 2016 May; 21:28-34. PMID: 27448468; PMCID: PMC4963611 [Available on 05/01/17].
      7. Corey-Bloom J, Gluhm S, Herndon A, Haque AS, Park S, Gilbert PE. Benton Judgment of Line Orientation (JoLO) Test: A Brief and Useful Measure for Assessing Visuospatial Abilities in Manifest, but not Premanifest, Huntington's Disease. J Huntingtons Dis. 2016; 5(1):91-6. PMID: 27003664.
        View in: PubMed
      8. Corey-Bloom J, Jia H, Aikin AM, Thomas EA. Disease Modifying Potential of Glatiramer Acetate in Huntington's Disease. J Huntingtons Dis. 2014; 3(3):311-6. PMID: 25300334; PMCID: PMC4480978.
      9. Pirogovsky E, Nicoll DR, Challener DM, Breen E, Gluhm S, Corey-Bloom J, Gilbert PE. The Visual Spatial Learning Test: differential impairment during the premanifest and manifest stages of Huntington's disease. J Neuropsychol. 2015 Mar; 9(1):77-86. PMID: 24330469.
        View in: PubMed
      10. Du J, Ma G, Li S, Carl M, Szeverenyi NM, VandenBerg S, Corey-Bloom J, Bydder GM. Ultrashort echo time (UTE) magnetic resonance imaging of the short T2 components in white matter of the brain using a clinical 3T scanner. Neuroimage. 2014 Feb 15; 87:32-41. PMID: 24188809; PMCID: PMC4091919.
      11. Majid DS, Cai W, Corey-Bloom J, Aron AR. Proactive selective response suppression is implemented via the basal ganglia. J Neurosci. 2013 Aug 14; 33(33):13259-69. PMID: 23946385; PMCID: PMC3742918.
      12. Maglione JE, Liu L, Neikrug AB, Poon T, Natarajan L, Calderon J, Avanzino JA, Corey-Bloom J, Palmer BW, Loredo JS, Ancoli-Israel S. Actigraphy for the assessment of sleep measures in Parkinson's disease. Sleep. 2013 Aug 01; 36(8):1209-17. PMID: 23904681; PMCID: PMC3700718.
      13. Gluhm S, Goldstein J, Brown D, Van Liew C, Gilbert PE, Corey-Bloom J. Usefulness of the Montreal Cognitive Assessment (MoCA) in Huntington's disease. Mov Disord. 2013 Oct; 28(12):1744-7. PMID: 23798501; PMCID: PMC4347861.
      14. Gluhm S, Goldstein J, Loc K, Colt A, Liew CV, Corey-Bloom J. Cognitive performance on the mini-mental state examination and the montreal cognitive assessment across the healthy adult lifespan. Cogn Behav Neurol. 2013 Mar; 26(1):1-5. PMID: 23538566; PMCID: PMC3638088.
      15. Mickes L, Wixted JT, Peavy GM, Jacobson MW, Goldstein JL, Corey-Bloom J. Difficulty modifying a sustained motor response in prodromal Huntington's disease. J Clin Exp Neuropsychol. 2013; 35(1):35-40. PMID: 23198997.
        View in: PubMed
      16. Lessig S, Nie D, Xu R, Corey-Bloom J. Changes on brief cognitive instruments over time in Parkinson's disease. Mov Disord. 2012 Aug; 27(9):1125-8. PMID: 22692724.
        View in: PubMed
      17. Corey-Bloom J, Wolfson T, Gamst A, Jin S, Marcotte TD, Bentley H, Gouaux B. Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial. CMAJ. 2012 Jul 10; 184(10):1143-50. PMID: 22586334; PMCID: PMC3394820.
      18. Corey-Bloom J. Treatment trials in aging and mild cognitive impairment. Curr Top Behav Neurosci. 2012; 10:347-56. PMID: 21786037.
        View in: PubMed
      19. Majid DS, Aron AR, Thompson W, Sheldon S, Hamza S, Stoffers D, Holland D, Goldstein J, Corey-Bloom J, Dale AM. Basal ganglia atrophy in prodromal Huntington's disease is detectable over one year using automated segmentation. Mov Disord. 2011 Dec; 26(14):2544-51. PMID: 21932302.
        View in: PubMed
      20. Seibert TM, Majid DS, Aron AR, Corey-Bloom J, Brewer JB. Stability of resting fMRI interregional correlations analyzed in subject-native space: a one-year longitudinal study in healthy adults and premanifest Huntington's disease. Neuroimage. 2012 Feb 01; 59(3):2452-63. PMID: 21945695; PMCID: PMC3254727.
      21. Majid DS, Stoffers D, Sheldon S, Hamza S, Thompson WK, Goldstein J, Corey-Bloom J, Aron AR. Automated structural imaging analysis detects premanifest Huntington's disease neurodegeneration within 1 year. Mov Disord. 2011 Jul; 26(8):1481-8. PMID: 21484871; PMCID: PMC3136652.
      22. Salomonczyk D, Panzera R, Pirogovosky E, Goldstein J, Corey-Bloom J, Simmons R, Gilbert PE. Impaired postural stability as a marker of premanifest Huntington's disease. Mov Disord. 2010 Oct 30; 25(14):2428-33. PMID: 20818666.
        View in: PubMed
      23. Mickes L, Jacobson M, Peavy G, Wixted JT, Lessig S, Goldstein JL, Corey-Bloom J. A comparison of two brief screening measures of cognitive impairment in Huntington's disease. Mov Disord. 2010 Oct 15; 25(13):2229-33. PMID: 20721924.
        View in: PubMed
      24. Peavy GM, Jacobson MW, Goldstein JL, Hamilton JM, Kane A, Gamst AC, Lessig SL, Lee JC, Corey-Bloom J. Cognitive and functional decline in Huntington's disease: dementia criteria revisited. Mov Disord. 2010 Jul 15; 25(9):1163-9. PMID: 20629124; PMCID: PMC2910142.
      25. Kieburtz K, McDermott MP, Voss TS, Corey-Bloom J, Deuel LM, Dorsey ER, Factor S, Geschwind MD, Hodgeman K, Kayson E, Noonberg S, Pourfar M, Rabinowitz K, Ravina B, Sanchez-Ramos J, Seely L, Walker F, Feigin A. A randomized, placebo-controlled trial of latrepirdine in Huntington disease. Arch Neurol. 2010 Feb; 67(2):154-60. PMID: 20142523; PMCID: PMC4134015.
      26. Cooke JR, Ancoli-Israel S, Liu L, Loredo JS, Natarajan L, Palmer BS, He F, Corey-Bloom J. Continuous positive airway pressure deepens sleep in patients with Alzheimer's disease and obstructive sleep apnea. Sleep Med. 2009 Dec; 10(10):1101-6. PMID: 19699148; PMCID: PMC2783482.
      27. Cooke JR, Ayalon L, Palmer BW, Loredo JS, Corey-Bloom J, Natarajan L, Liu L, Ancoli-Israel S. Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer's disease and obstructive sleep apnea: a preliminary study. J Clin Sleep Med. 2009 Aug 15; 5(4):305-9. PMID: 19968005; PMCID: PMC2725246.
      28. Jak AJ, Urban S, McCauley A, Bangen KJ, Delano-Wood L, Corey-Bloom J, Bondi MW. Profile of hippocampal volumes and stroke risk varies by neuropsychological definition of mild cognitive impairment. J Int Neuropsychol Soc. 2009 Nov; 15(6):890-7. PMID: 19570306; PMCID: PMC2864786.
      29. Jak AJ, Bondi MW, Delano-Wood L, Wierenga C, Corey-Bloom J, Salmon DP, Delis DC. Quantification of five neuropsychological approaches to defining mild cognitive impairment. Am J Geriatr Psychiatry. 2009 May; 17(5):368-75. PMID: 19390294; PMCID: PMC2743175.
      30. Gehrman PR, Connor DJ, Martin JL, Shochat T, Corey-Bloom J, Ancoli-Israel S. Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease. Am J Geriatr Psychiatry. 2009 Feb; 17(2):166-9. PMID: 19155748; PMCID: PMC2630117.
      31. Jak AJ, Bangen KJ, Wierenga CE, Delano-Wood L, Corey-Bloom J, Bondi MW. Contributions of neuropsychology and neuroimaging to understanding clinical subtypes of mild cognitive impairment. Int Rev Neurobiol. 2009; 84:81-103. PMID: 19501714; PMCID: PMC2864107.
      32. Ancoli-Israel S, Palmer BW, Cooke JR, Corey-Bloom J, Fiorentino L, Natarajan L, Liu L, Ayalon L, He F, Loredo JS. Cognitive effects of treating obstructive sleep apnea in Alzheimer's disease: a randomized controlled study. J Am Geriatr Soc. 2008 Nov; 56(11):2076-81. PMID: 18795985; PMCID: PMC2585146.
      33. Marcotte TD, Rosenthal TJ, Roberts E, Lampinen S, Scott JC, Allen RW, Corey-Bloom J. The contribution of cognition and spasticity to driving performance in multiple sclerosis. Arch Phys Med Rehabil. 2008 Sep; 89(9):1753-8. PMID: 18760160; PMCID: PMC4560356.
      34. Fine EM, Delis DC, Wetter SR, Jacobson MW, Hamilton JM, Peavy G, Goldstein J, McDonald C, Corey-Bloom J, Bondi MW, Salmon DP. Identifying the "source" of recognition memory deficits in patients with Huntington's disease or Alzheimer's disease: evidence from the CVLT-II. J Clin Exp Neuropsychol. 2008 May; 30(4):463-70. PMID: 18415887; PMCID: PMC2864091.
      35. Yaari R, Corey-Bloom J. Alzheimer's disease. Semin Neurol. 2007 Feb; 27(1):32-41. PMID: 17226739.
        View in: PubMed
      36. Chong MS, Ayalon L, Marler M, Loredo JS, Corey-Bloom J, Palmer BW, Liu L, Ancoli-Israel S. Continuous positive airway pressure reduces subjective daytime sleepiness in patients with mild to moderate Alzheimer's disease with sleep disordered breathing. J Am Geriatr Soc. 2006 May; 54(5):777-81. PMID: 16696743.
        View in: PubMed
      37. Ayalon L, Ancoli-Israel S, Stepnowsky C, Marler M, Palmer BW, Liu L, Loredo JS, Corey-Bloom J, Greenfield D, Cooke J. Adherence to continuous positive airway pressure treatment in patients with Alzheimer's disease and obstructive sleep apnea. Am J Geriatr Psychiatry. 2006 Feb; 14(2):176-80. PMID: 16473983.
        View in: PubMed
      38. Han SD, Houston WS, Jak AJ, Eyler LT, Nagel BJ, Fleisher AS, Brown GG, Corey-Bloom J, Salmon DP, Thal LJ, Bondi MW. Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response. Neurobiol Aging. 2007 Feb; 28(2):238-47. PMID: 16434125; PMCID: PMC1705815.
      39. Cooke JR, Loredo JS, Liu L, Marler M, Corey-Bloom J, Fiorentino L, Harrison T, Ancoli-Israel S. Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease. Drugs Aging. 2006; 23(6):503-11. PMID: 16872233.
        View in: PubMed
      40. Cooke JR, Liu L, Natarajan L, He F, Marler M, Loredo JS, Corey-Bloom J, Palmer BW, Greenfield D, Ancoli-Israel S. The effect of sleep-disordered breathing on stages of sleep in patients with Alzheimer's disease. Behav Sleep Med. 2006; 4(4):219-27. PMID: 17083302.
        View in: PubMed
      41. Polich J, Corey-Bloom J. Alzheimer's disease and P300: review and evaluation of task and modality. Curr Alzheimer Res. 2005 Dec; 2(5):515-25. PMID: 16375655.
        View in: PubMed
      42. Gehrman P, Marler M, Martin JL, Shochat T, Corey-Bloom J, Ancoli-Israel S. The timing of activity rhythms in patients with dementia is related to survival. J Gerontol A Biol Sci Med Sci. 2004 Oct; 59(10):1050-5. PMID: 15528777.
        View in: PubMed
      43. Ancoli-Israel S, Martin JL, Gehrman P, Shochat T, Corey-Bloom J, Marler M, Nolan S, Levi L. Effect of light on agitation in institutionalized patients with severe Alzheimer disease. Am J Geriatr Psychiatry. 2003 Mar-Apr; 11(2):194-203. PMID: 12611749.
        View in: PubMed
      44. Ancoli-Israel S, Gehrman P, Martin JL, Shochat T, Marler M, Corey-Bloom J, Levi L. Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer's disease patients. Behav Sleep Med. 2003; 1(1):22-36. PMID: 15600135.
        View in: PubMed
      Jody's Networks
      Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Similar People
      People who share similar concepts with this person.
      _
      Same Department
      Physical Neighbors
      People whose addresses are nearby this person.
      _